Trials / Not Yet Recruiting
Not Yet RecruitingNCT07527130
C11 ER176 PET in Evaluating Neuroinflammation in Patients With Post-COVID Syndrome
- Status
- Not Yet Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 10 (estimated)
- Sponsor
- Mayo Clinic · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this research is to find out if Positron Emission Tomography (PET) imaging with an investigational drug called C-11 ER176 can help us learn more about Post-COVID Syndrome.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | C11 ER176 Tracer | C11 ER176 tracer will be administered by IV, followed by PET imaging of the brain to evaluate for neuroinflammation |
Timeline
- Start date
- 2026-05-01
- Primary completion
- 2027-12-01
- Completion
- 2027-12-01
- First posted
- 2026-04-14
- Last updated
- 2026-04-14
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT07527130. Inclusion in this directory is not an endorsement.